30.11.2014 Views

Zhone Technologies Annual Report 2004

Zhone Technologies Annual Report 2004

Zhone Technologies Annual Report 2004

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

2002 and no longer amortizes goodwill. The Company evaluates goodwill, at a minimum, on an annual<br />

basis and whenever events and changes in circumstances suggest that the carrying amount may not be<br />

recoverable. Impairment of goodwill is tested at the reporting unit level by comparing the reporting unit’s<br />

carrying amount, including goodwill, to the fair value of the reporting unit. The Company has determined<br />

that it operates in a single segment with one operating unit. In 2002, the fair value of the reporting unit was<br />

estimated using a combination of the income, or discounted cash flows, approach and the market approach,<br />

which utilized comparable companies’ data. Effective November 2003, the Company performs the annual<br />

goodwill impairment test using the market approach, reflecting the fact that the Company’s stock was<br />

publicly traded following the consummation of the Tellium merger. If the carrying amount of the reporting<br />

unit exceeds its fair value, goodwill is considered impaired and a second step is performed to measure the<br />

amount of impairment loss, if any.<br />

(m) Purchased Intangibles and Other Long-Lived Assets<br />

In accordance with SFAS No. 144, long-lived assets, such as property, plant and equipment, and<br />

purchased intangibles subject to amortization, are reviewed for impairment whenever events or changes in<br />

circumstances indicate that the carrying amount of an asset may not be fully recoverable. Recoverability of<br />

assets to be held and used is measured by a comparison of the carrying amount of an asset to future net<br />

undiscounted cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its<br />

estimated future cash flows, an impairment charge is recognized by the amount by which the carrying<br />

amount of the asset exceeds the fair value of the asset. During the year ended December 31, 2002, the<br />

Company recorded an impairment loss on long-lived assets of $50.8 million. Any assets to be disposed of<br />

would be separately presented in the balance sheet and reported at the lower of the carrying amount or fair<br />

value less costs to sell, and would no longer be depreciated. The assets and liabilities of a disposed group<br />

classified as held for sale would be presented separately in the appropriate asset and liability sections of the<br />

balance sheet.<br />

Goodwill and other acquisition-related intangible assets not subject to amortization are tested annually<br />

for impairment, and are tested for impairment more frequently if events and circumstances indicate that the<br />

asset might be impaired. An impairment loss is recognized to the extent that the carrying amount exceeds<br />

the asset’s fair value. During the year ended December 31, <strong>2004</strong>, the Company recorded a charge of $0.2<br />

million related to impairment of the acquired workforce from Gluon.<br />

(n) Research and Product Development Expenditures<br />

Costs related to research, design, and development of products are charged to research and product<br />

development expense as incurred. Costs for the development of new software and substantial enhancements<br />

to existing software are expensed as incurred until technological feasibility has been established, at which<br />

time any additional development costs would be capitalized. The Company’s current process for developing<br />

software is essentially completed concurrently with the establishment of technological feasibility;<br />

accordingly, no costs have been capitalized to date.<br />

(o) Accounting for Stock-Based Compensation<br />

The Company has elected to account for employee stock options using the intrinsic-value method in<br />

accordance with Accounting Principles Board Opinion No. 25 (“APB 25”) and related interpretations.<br />

Under this method, compensation expense is recorded on the date of grant only if the current fair value<br />

exceeds the exercise price. SFAS No. 123, Accounting for Stock-Based Compensation, established<br />

accounting and disclosure requirements using a fair value-based method of accounting for stock-based<br />

employee compensation plans. As allowed by SFAS No. 123, the Company has elected to continue to apply<br />

the intrinsic value-based method of accounting described above, and has adopted the disclosure<br />

requirements of SFAS No. 123, as amended.<br />

38

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!